Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
An update from Oncimmune Holdings ( (GB:ONC) ) is now available.
Oncimmune Holdings PLC has announced a change in its major holdings due to the acquisition or disposal of financial instruments by Spreadex LTD. As of February 3, 2025, Spreadex LTD has adjusted its percentage of voting rights in Oncimmune, reflecting a new distribution of financial instruments. This adjustment marks a shift in the stakeholder composition of Oncimmune, potentially impacting its strategic decisions and investor relations. The change in voting rights may affect the company’s governance and influence future business directions.
More about Oncimmune Holdings
Oncimmune Holdings PLC is involved in the healthcare industry, specializing in the development of advanced diagnostic tests to aid in the early detection of diseases. The company focuses on creating products that enhance the detection and diagnosis of cancer, aiming to improve patient outcomes and contribute significantly to the healthcare market.
YTD Price Performance: -29.62%
Average Trading Volume: 235,984
Technical Sentiment Consensus Rating: Buy
Current Market Cap: £11.29M
For a thorough assessment of ONC stock, go to TipRanks’ Stock Analysis page.
